Refocusing on family readiness: How RAND can support the U.S. Air Force

Abstract: This brochure highlights PAF research from 2001 to 2024 that addresses key needs underscored in the Chief of Staff of the USAF (CSAF) August 16, 2024, memorandum “Refocusing Family Readiness”: theneeds to “prepare the force for future challenges,” to “focus on familyreadiness,” and to “ensure that families and communities connectedto the Air Force are as well prepared as our service members for the possible challenges that lay ahead.”1 This brochure organizes relevant RAND research into three categories that align with recent and ongoing USAF efforts to improve programs and approaches highlighted in the memorandum: (a) Relocation Assistance Program, (b) True North, and (c) Connect to Care. Also included are exemplars of research from other RAND divisions (outside PAF) conducted for the sister services, the Office of the Secretary of Defense, and other federal government agencies.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.